Filing Flows › Envoy Medical (COCH) › Q4 2025
Envoy Medical (COCH) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 23, 2026
Envoy Medical (COCH) reported revenue of $75K for the fourth quarter 2025 (Q4 2025), +79% from a year earlier and +79% from the quarter before.
Envoy Medical, Q4 2025: revenue $75K (+79% year over year), net loss $6.6M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75K | +79% | +79% |
| Operating profit | −$6.4M | — | — |
| Net earnings | −$6.6M | — | — |
| Operating cash flow | −$5.7M | — | — |
What changed
Revenue was $75K in Q4 2025, up 79% year over year and up 79% from the previous quarter.
Operating costs exceeded revenue by $6.4M, an operating margin of -8513.3%. Total costs grew 41% against revenue growth of 79%. The fastest-growing cost line was Research & development (+84%). The quarter ended with a net loss of $6.6M, wider than the previous quarter's $6.5M loss.
Operating cash flow was −$5.7M. Non-cash charges added back $80K of depreciation and $179K of share-based compensation. Working capital and other items added $642K. Capital expenditures of $172K exceeded it, leaving free cash flow of −$5.9M.
Questions
What was Envoy Medical's revenue in the fourth quarter 2025?
Envoy Medical (COCH) reported revenue of $75K for the fourth quarter 2025 (Q4 2025), +79% from a year earlier and +79% from the quarter before.
Source: Envoy Medical 10-K on SEC EDGAR.